10-K Filing

ENZON PHARMACEUTICALS, INC. CIK: 727510 FY 2017

Filing Information

Form Type	10-K
Accession Number	`0001144204-18-016199`
Period End Date	20171231
Filing Date	20180321
Fiscal Year	2017
Fiscal Period	FY
XBRL Instance	enzn-20171231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 51 Income Statement 26 Cash Flow Statement 33 Stockholders Equity 10

Balance Sheet 51 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$7.64M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$7.48M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$11.67M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$270.00K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$94.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$7.91M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Total current assets	`AssetsCurrent`	$7.57M	USD	Point-in-time
Refundable tax credits receivable	`IncomeTaxesReceivableNoncurrent`	-	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Refundable tax credits receivable	`IncomeTaxesReceivableNoncurrent`	$1.94M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Deferred tax assets	`DeferredTaxAssetsLiabilitiesNetNoncurrent`	$3.36M	USD	Point-in-time
Deferred tax assets	`DeferredTaxAssetsLiabilitiesNetNoncurrent`	-	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.21M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.21M	shares	Point-in-time
Total assets	`Assets`	$9.51M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.21M	shares	Point-in-time
Total assets	`Assets`	$11.27M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.21M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$770.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$213.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$225.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$143.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$170.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$940.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$368.00K	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at December 31, 2017 and 2016	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at December 31, 2017 and 2016	`PreferredStockValue`	-	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 44,214,603 shares at December 31, 2017 and 2016	`CommonStockValue`	$442.00K	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 44,214,603 shares at December 31, 2017 and 2016	`CommonStockValue`	$442.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$90.28M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$83.65M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-80.39M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-74.95M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$9.14M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$18.09M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$10.33M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$9.51M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$11.27M	USD	Point-in-time

Income Statement 26 line items

Line Item	Tag	Value	Unit	Period
Royalties	`RoyaltyRevenue`	$8.31M	USD	Annual
Royalties	`RoyaltyRevenue`	$8.38M	USD	Annual
Miscellaneous income	`OtherSalesRevenueNet`	-	USD	Annual
Miscellaneous income	`OtherSalesRevenueNet`	$63.00K	USD	Annual
Total revenues	`SalesRevenueNet`	$8.38M	USD	Annual
Total revenues	`SalesRevenueNet`	$8.38M	USD	Annual
General and administrative	`OtherGeneralAndAdministrativeExpense`	$1.68M	USD	Annual
General and administrative	`OtherGeneralAndAdministrativeExpense`	$1.37M	USD	Annual
Lease termination costs	`GainLossOnContractTermination`	$-54.00K	USD	Annual
Lease termination costs	`GainLossOnContractTermination`	-	USD	Annual
Total operating expenses	`OperatingExpenses`	$1.73M	USD	Annual
Total operating expenses	`OperatingExpenses`	$1.37M	USD	Annual
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$7.01M	USD	Annual
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$6.64M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$1.56M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$7.77M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-1.13M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$5.45M	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.03	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.12	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.03	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.12	USD	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44.22M	shares	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44.22M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.22M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.22M	shares	Annual

Cash Flow Statement 33 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-1.13M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$5.45M	USD	Annual
Deferred tax provision	`DeferredIncomeTaxExpenseBenefit`	$7.75M	USD	Annual
Deferred tax provision	`DeferredIncomeTaxExpenseBenefit`	$3.36M	USD	Annual
(Decrease) increase in other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$163.00K	USD	Annual
(Decrease) increase in other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$-176.00K	USD	Annual
Increase in refundable tax credit receivable	`IncreaseDecreaseInLongTermReceivablesCurrent`	$1.94M	USD	Annual
Increase in refundable tax credit receivable	`IncreaseDecreaseInLongTermReceivablesCurrent`	-	USD	Annual
Decrease in accrued lease termination costs	`IncreseDecreseInAccruedLeaseTerminationCosts`	-	USD	Annual
Decrease in accrued lease termination costs	`IncreseDecreseInAccruedLeaseTerminationCosts`	$-4.51M	USD	Annual
Increase (decrease) in accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$-545.00K	USD	Annual
Increase (decrease) in accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$680.00K	USD	Annual
Decrease in accrued expenses and other current liabilities	`IncreaseDecreaseInOtherAccruedLiabilities`	$-27.00K	USD	Annual
Decrease in accrued expenses and other current liabilities	`IncreaseDecreaseInOtherAccruedLiabilities`	$-35.00K	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.60M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$6.47M	USD	Annual
Common stock dividends	`PaymentsOfDividendsCommonStock`	$6.60M	USD	Point-in-time
Common stock dividends	`PaymentsOfDividendsCommonStock`	$6.60M	USD	Point-in-time
Common stock dividends	`PaymentsOfDividendsCommonStock`	$6.63M	USD	Annual
Common stock dividends	`PaymentsOfDividendsCommonStock`	$6.60M	USD	Point-in-time
Common stock dividends	`PaymentsOfDividendsCommonStock`	$6.63M	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-6.63M	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-6.63M	USD	Annual
Net decrease in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-161.00K	USD	Annual
Net decrease in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-4.03M	USD	Annual
Cash at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$7.64M	USD	Point-in-time
Cash at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$7.48M	USD	Point-in-time
Cash at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$11.67M	USD	Point-in-time
Cash at end of year	`CashAndCashEquivalentsAtCarryingValue`	$7.64M	USD	Point-in-time
Cash at end of year	`CashAndCashEquivalentsAtCarryingValue`	$7.48M	USD	Point-in-time
Cash at end of year	`CashAndCashEquivalentsAtCarryingValue`	$11.67M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaid`	$135.00M	USD	Annual

Stockholders Equity 10 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$9.14M	USD	Point-in-time
Balance	`StockholdersEquity`	$18.09M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.33M	USD	Point-in-time
Net loss	`NetIncomeLoss`	$-1.13M	USD	Annual
Net loss	`NetIncomeLoss`	$5.45M	USD	Annual
Common stock dividend	`DividendsCommonStockStock`	$6.63M	USD	Annual
Common stock dividend	`DividendsCommonStockStock`	$6.63M	USD	Annual
Balance	`StockholdersEquity`	$9.14M	USD	Point-in-time
Balance	`StockholdersEquity`	$18.09M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.33M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.